Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter regulatory Response to Hypoglycemia in Type 1 Diabetes BB Rats

被引：0
|
作者：
Qin, Tairan
Karimian, Negar
Osundiji, Mayowa
Huang, Yachi
Coy, David H.
Vranic, Mladen
Gaisano, Herbert Y.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
176-OR
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] Normalization of the Glucagon Response to Hypoglycemia in STZ-Diabetic Rats Via Somatostatin Type 2 Receptor Antagonism
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2009, 58 : A35 - A35
  • [2] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
    Karimian, Negar
    Qin, Tairan
    Liang, Tao
    Osundiji, Mayowa
    Huang, Yachi
    Teich, Trevor
    Riddell, Michael C.
    Cattral, Mark S.
    Coy, David H.
    Vranic, Mladen
    Gaisano, Herbert Y.
    DIABETES, 2013, 62 (08) : 2968 - 2977
  • [3] Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Giacca, Adria
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2012, 61 (01) : 197 - 207
  • [4] Somatostatin type 2 receptor antagonism improves glucagon and corticosterone counterregulation to hypoglycaemia in STZ-diabetic rats
    Yue, J. T. Y.
    Burdett, E.
    Coy, D. H.
    Efendic, S.
    Vranic, M.
    DIABETOLOGIA, 2009, 52 : S236 - S237
  • [5] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2010, 59 : A205 - A206
  • [6] Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
    Yue, Jessica T. Y.
    Riddell, Michael C.
    Burdett, Elena
    Coy, David H.
    Efendic, Suad
    Vranic, Mladen
    DIABETES, 2013, 62 (07) : 2215 - 2222
  • [7] Somatostatin Receptor 2 Antagonism Enhances Plasma Glucagon Levels during Insulin-Induced Hypoglycemia in a Rodent Model of Type 2 Diabetes Mellitus
    Nejad-Mansouri, Mehran
    Bavani, Parinaz Zaree
    Aiken, Julian
    Dsouza, Ninoschka C.
    Hoffman, Emily G.
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2019, 68
  • [8] Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia
    Gautier, J. F.
    Dejager, S.
    Foley, J.
    Halimi, S.
    Ahren, B.
    DIABETES & METABOLISM, 2009, 35 : A8 - A8
  • [9] Somatostatin Receptor II Antagonism Improves Glucagon Counterregulatory Responses to Recurrent Hypoglycemia in Male Sprague-Dawley Rats
    Riddell, Michael
    Jahangiriesmaili, Mahsa
    Mandel, Erin R.
    Greenberg, Caylee A.
    Pasieka, Aoibhe M.
    Teich, Trevor
    Chan, Owen
    Liggins, Richard T.
    DIABETES, 2018, 67
  • [10] Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats
    Hoffman, Emily G.
    Dsouza, Ninoschka
    Aiken, Julian
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2021, 70
12345